478 related articles for article (PubMed ID: 33773190)
1. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM
Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190
[TBL] [Abstract][Full Text] [Related]
2. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
[TBL] [Abstract][Full Text] [Related]
3. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
[TBL] [Abstract][Full Text] [Related]
4. Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.
Yang Q; Ren GL; Wei B; Jin J; Huang XR; Shao W; Li J; Meng XM; Lan HY
Theranostics; 2019; 9(26):8277-8293. PubMed ID: 31754396
[No Abstract] [Full Text] [Related]
5. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death.
Gao L; Liu MM; Zang HM; Ma QY; Yang Q; Jiang L; Ren GL; Li HD; Wu WF; Wang JN; Wei B; Liu XQ; Jiang C; Huang C; Li J; Meng XM
Lab Invest; 2018 Jul; 98(7):911-923. PubMed ID: 29581579
[TBL] [Abstract][Full Text] [Related]
6. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.
Meng XM; Li HD; Wu WF; Ming-Kuen Tang P; Ren GL; Gao L; Li XF; Yang Y; Xu T; Ma TT; Li Z; Huang C; Zhang L; Lv XW; Li J
Lab Invest; 2018 Jan; 98(1):79-94. PubMed ID: 29200200
[TBL] [Abstract][Full Text] [Related]
7. Eleutheroside B Protects against Acute Kidney Injury by Activating IGF Pathway.
Zang H; Yang Q; Li J
Molecules; 2019 Oct; 24(21):. PubMed ID: 31661774
[TBL] [Abstract][Full Text] [Related]
8. Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism.
Liu Q; Chen X; Kan M; Yang J; Gong Q; Jin R; Dai Y; Jin J; Zang H
Eur J Pharmacol; 2021 Nov; 910():174501. PubMed ID: 34529980
[TBL] [Abstract][Full Text] [Related]
9. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
10. Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis.
Wang F; Wang JN; He XY; Suo XG; Li C; Ni WJ; Cai YT; He Y; Fang XY; Dong YH; Xing T; Yang YR; Zhang F; Zhong X; Zang HM; Liu MM; Li J; Meng XM; Jin J
Acta Pharmacol Sin; 2022 Feb; 43(2):330-341. PubMed ID: 33833407
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a chalcone derivative as potent necroptosis inhibitor for the treatment of acute kidney injury.
Li C; Chen QY; He Y; Liu YH; Meng XM; Liu MM
Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):824-835. PubMed ID: 35579574
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
13. Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress.
Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
Int Immunopharmacol; 2024 Jan; 127():111420. PubMed ID: 38142642
[TBL] [Abstract][Full Text] [Related]
14. Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death.
Shan RR; Yu JT; Zhang SF; Xie MM; Hou R; Xie CY; Dong ZH; Yang Q; Hu XW; Dong YH; Zhang Y; Luo XF; Cui ZY; Liu XY; Xie YC; Wen JG; Liu MM; Jin J; Chen Q; Meng XM
Phytomedicine; 2024 Jan; 123():155252. PubMed ID: 38056145
[TBL] [Abstract][Full Text] [Related]
15. Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway.
Xie KH; Liu XH; Jia J; Zhong X; Han RY; Tan RZ; Wang L
Int Immunopharmacol; 2022 Nov; 112():109247. PubMed ID: 36155281
[TBL] [Abstract][Full Text] [Related]
16. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.
Yang C; Guo Y; Huang TS; Zhao J; Huang XJ; Tang HX; An N; Pan Q; Xu YZ; Liu HF
Biomed Pharmacother; 2018 Nov; 107():1354-1362. PubMed ID: 30257350
[TBL] [Abstract][Full Text] [Related]
17. Artesunate relieves acute kidney injury through inhibiting macrophagic Mincle-mediated necroptosis and inflammation to tubular epithelial cell.
Lei XY; Tan RZ; Jia J; Wu SL; Wen CL; Lin X; Wang H; Shi ZJ; Li B; Kang Y; Wang L
J Cell Mol Med; 2021 Sep; 25(18):8775-8788. PubMed ID: 34337860
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of 6-Shogaol, an Active Compound of Ginger, in a Murine Model of Cisplatin-Induced Acute Kidney Injury.
Gwon MG; Gu H; Leem J; Park KK
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641472
[TBL] [Abstract][Full Text] [Related]
19. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells.
Jiang L; Liu XQ; Ma Q; Yang Q; Gao L; Li HD; Wang JN; Wei B; Wen J; Li J; Wu YG; Meng XM
FASEB J; 2019 Mar; 33(3):3523-3535. PubMed ID: 30365367
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.
Yu JT; Hu XW; Yang Q; Shan RR; Zhang Y; Dong ZH; Li HD; Wang JN; Li C; Xie SS; Dong YH; Ni WJ; Jiang L; Liu XQ; Wei B; Wen JG; Liu MM; Chen Q; Yang YR; Zhang GY; Zang HM; Jin J; Wu YG; Zhong X; Li J; Wang W; Meng XM
Kidney Int; 2022 Oct; 102(4):828-844. PubMed ID: 35752325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
